More than 1,300 women to get breakthrough cancer drug A breakthrough breast cancer drug is due to be provided routinely for the first time, after the NHS chief executive stepped in to broker a deal.
More than 1,300 women with advanced cancer are expected to get the Perjeta treatment on the NHS.
The treatment – for the aggressive HER2+ form of the disease – extends life for women dying with breast cancer by an average 56 months, 16 months more than the next best treatment. The Daily Mail
See also:
More than 1,300 women with advanced cancer are expected to get the Perjeta treatment on the NHS.
The treatment – for the aggressive HER2+ form of the disease – extends life for women dying with breast cancer by an average 56 months, 16 months more than the next best treatment. The Daily Mail
See also:
No comments:
Post a Comment